AKT1 and cancer: Furthermore, mTOR plays a key role in the phosphatidylinositol 3-kinase (PI3K)/AKT pathway which is frequently dysregulated and implicated in the growth and progression in several cancers, making it an attractive therapeutic target [10], [11].